Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002088353 | SCV002387388 | likely benign | Myofibrillar myopathy 4 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002346415 | SCV002652953 | likely benign | Cardiovascular phenotype | 2020-06-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994393 | SCV004813000 | likely benign | not specified | 2024-02-05 | criteria provided, single submitter | clinical testing |